FDA OKs Phase 1 study of two-component immunotherapy
The FDA approved the launch of a clinical trial to evaluate the safety and effectiveness of its two-component immunotherapy for lupus.| Lupus News Today
The FDA approved the launch of a clinical trial to evaluate the safety and effectiveness of its two-component immunotherapy for lupus.| Lupus News Today
Author archive page for Lindsey Shapiro.| Lupus News Today
